ArticleJournal of the American Geriatrics Society2022
Deprescribing trials: A focus on adverse drug withdrawal events.
Article in Journal of the American Geriatrics Society, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 18 papers, 1 of them a synthesis that pooled it.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
18 citing papers in PubMed, 1 synthesis or guideline pooled it.
- Criteria to Report Adverse Drug Withdrawal Events in Clinical Trials: A Systematic Review.Journal of the American Geriatrics Society · 2025Pooled it
- Effectiveness of Patient-Directed Education to Sustain Deprescribing: A Pragmatic Trial.Drugs & aging · 2025Trial
- Strengthening Pharmacovigilance Reporting for Withdrawal Reactions to Support Deprescribing.Clinical pharmacology and therapeutics · 2026Review
- Reporting patterns of adverse drug withdrawal events using individual case safety reports in the FAERS and Eudravigilance databases.Exploratory research in clinical and social pharmacy · 2026Article
- Article
- Restarting Medications After Deprescribing in Adults Discharged From Hospital to Skilled Nursing.JAMA network open · 2026Article
- Hospital readmissions related to adverse drug withdrawal events in older adults: a pilot study.International journal of clinical pharmacy · 2026Article
- Clinical Pharmacology of Heart Failure in Frailty.European cardiology · 2026Review
- Towards a Balanced View of Benefits and Harms in Deprescribing Trials.Journal of the American Geriatrics Society · 2025Article
- Assessing causality in deprescribing studies: A focus on adverse drug events and adverse drug withdrawal events.Journal of the American Geriatrics Society · 2025Article
- Emergency department visits and hospital readmissions after a deprescribing intervention among hospitalized older adults.Journal of the American Geriatrics Society · 2024Article
- Medication use quality and safety in older adults: 2022 update.Journal of the American Geriatrics Society · 2024Review
- Deprescribing electronic case reviews for older veterans at risk for falls: Effects on drug burden and falls.Journal of the American Geriatrics Society · 2024Article
- Article
- Article
- Co-designing an intervention to improve the process of deprescribing for older people living with frailty in the United Kingdom.Health expectations : an international journal of public participation in health care and health policy · 2023Article
- Developing a core outcome set for hospital deprescribing trials for older people under the care of a geriatrician.Age and ageing · 2022Article
- A Pathway to Healthier Aging or an Illusion? A Narrative Review on Deprescribing Protocols for the Elderly.Sage open agingReview
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors.
Funding
Abstract
PubMed holds no abstract for this paper.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.